Advanced Therapies – Page 33 – Discover Pharma

Welcome to Discover Pharma! Today is : November 7, 2026

Advanced Therapies

Advanced Therapies,Clinical & Regulatory,Drug Delivery & Formulation
EXCLUSIVE: Trust on trial – why vaccine volunteers are saying ‘no’
May 5, 2026
Advanced Therapies,Biotech & Pharma Business
Cellevate consortium secures €1M Eurostars grant to boost iPSC manufacturing at scale
May 5, 2026
Advanced Therapies
MaaT Pharma unveils promising preclinical data for synthetic microbiome therapy MaaT034 at AACR
May 5, 2026
Advanced Therapies
Crown Bioscience launches 3D bone marrow niche models to advance hematological cancer research
At AACR 2025, Crown Bioscience introduced its new 3D bone [...]

May 5, 2026
Advanced Therapies
Cycuria Therapeutics launches with advisory board and major grant funding
May 5, 2026
Advanced Therapies
Cellevate, Fraunhofer IBMT, and OLS secure Eurostar grant to advance large-scale iPSC production
Cellevate AB, Fraunhofer IBMT, and Omni Life Science (OLS) have [...]

May 5, 2026
Advanced Therapies
BioSkryb Genomics and Tecan launch single-cell multiomics workflow for faster sequencing
May 5, 2026
Advanced Therapies
Hydrogel breakthrough could boost liver cell therapy durability, Likarda paper shows
May 5, 2026
Advanced Therapies
Cellistic unveils Echo-NK platform to scale up iPSC-based cell therapies
May 5, 2026
Advanced Therapies
Sphere Bio expands APAC distribution network to support single-cell analysis demand
May 5, 2026

main menu

recent posts

get connected

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK